El-Haddad Mostafa A, Ismail Yaser, Gayle Dave, Ross Michael G
David Geffen UCLA Medical School, Research and Educational Institute, Harbor/UCLA Medical Center, 1124 W. Carson St., RB-1, Torrance, CA 90502, USA.
Am J Physiol Regul Integr Comp Physiol. 2005 Apr;288(4):R1014-20. doi: 10.1152/ajpregu.00479.2003. Epub 2004 Nov 18.
Swallowed volumes in the fetus are greater than adult values (per body weight) and serve to regulate amniotic fluid volume. Central ANG II stimulates swallowing, and nonspecific ANG II receptor antagonists inhibit both spontaneous and ANG II-stimulated swallowing. In the adult rat, AT1 receptors mediate both stimulated drinking and pressor activities, while the role of AT2 receptors is controversial. As fetal brain contains increased ANG II receptors compared with the adult brain, we sought to investigate the role of both AT1 and AT2 receptors in mediating fetal swallowing and pressor activities. Five pregnant ewes with singleton fetuses (130 +/- 1 days) were prepared with fetal vascular and lateral ventricle (LV) catheters and electrocorticogram and esophageal electromyogram electrodes and received three studies over 5 days. On day 1 (ANG II), following a 2-h basal period, 1 ml artificial cerebrospinal fluid (aCSF) was injected in the LV. At time 4 h, ANG II (6.4 microg) was injected in the LV, and the fetus was monitored for a final 2 h. On day 3, AT1 receptor blocker (losartan 0.5 mg) was administered at 2 h, and ANG II plus losartan was administered at 4 h. On day 5, AT2 receptor blocker (PD-123319; 0.8 mg was administered at 2 h and ANG II plus PD-123319 at 4 h. In the ANG II study, LV injection of ANG II significantly increased fetal swallowing (0.9 +/- 0.1 to 1.4 +/- 0.1 swallows/min; P < 0.05). In the losartan study, basal fetal swallowing significantly decreased in response to blockade of AT1 receptors (0.9 +/- 0.1 to 0.4 +/- 0.1 swallows/min; P < 0.05), while central injection of ANG II in the presence of AT1 receptor antagonism did not increase fetal swallowing (0.6 +/- 0.1 swallows/min). In the PD-123319 study, basal fetal swallowing did not change in response to blockade of AT2 receptor (0.9 +/- 0.1 swallows/min), while central injection of ANG II in the presence of AT2 blockade significantly increased fetal swallowing (1.5 +/- 0.1 swallows/min; P < 0.05). ANG II caused significant pressor responses in the control and PD-123319 studies but no pressor response in the presence of AT1 blockade. These data demonstrate that in the near-term ovine fetus, AT1 receptor but not AT2 receptors accessible via CSF contribute to dipsogenic and pressor responses.
胎儿吞咽的量(按体重计算)大于成人,其作用是调节羊水量。中枢血管紧张素II(ANG II)刺激吞咽,非特异性ANG II受体拮抗剂可抑制自发吞咽和ANG II刺激的吞咽。在成年大鼠中,AT1受体介导刺激饮水和升压活动,而AT2受体的作用存在争议。由于与成年大脑相比,胎儿大脑中ANG II受体增加,我们试图研究AT1和AT2受体在介导胎儿吞咽和升压活动中的作用。对5只怀有单胎胎儿(130±1天)的怀孕母羊进行准备,植入胎儿血管和侧脑室(LV)导管以及脑电图和食管肌电图电极,并在5天内进行三项研究。第1天(ANG II),在2小时的基础期后,向LV注射1毫升人工脑脊液(aCSF)。4小时时,向LV注射ANG II(6.4微克),并对胎儿进行最后2小时的监测。第3天,在2小时时给予AT1受体阻滞剂(氯沙坦0.5毫克),4小时时给予ANG II加氯沙坦。第5天,在2小时时给予AT2受体阻滞剂(PD - 123319;0.8毫克),4小时时给予ANG II加PD - 123319。在ANG II研究中,LV注射ANG II显著增加胎儿吞咽(从0.9±0.1次/分钟增加到1.4±0.1次/分钟;P<0.05)。在氯沙坦研究中,AT1受体被阻断后,基础胎儿吞咽显著减少(从0.9±0.1次/分钟减少到0.4±0.1次/分钟;P<0.05),而在存在AT1受体拮抗作用的情况下,向中枢注射ANG II并未增加胎儿吞咽(0.6±0.1次/分钟)。在PD - 123319研究中,AT2受体被阻断后,基础胎儿吞咽没有变化(0.9±0.1次/分钟),而在存在AT2阻断的情况下,向中枢注射ANG II显著增加胎儿吞咽(1.5±0.1次/分钟;P<0.05)。在对照和PD - 123319研究中,ANG II引起显著的升压反应,但在存在AT1阻断时没有升压反应。这些数据表明,在近足月绵羊胎儿中,通过脑脊液可及的AT1受体而非AT2受体参与了致渴和升压反应。